Blood NfL Levels May Mark SMA Severity, Therapy Efficacy in Very Young

Sep 30, 2021, 12:00 AM

SMA News Today’s multimedia associate, Price Wooldridge, discusses how blood neurofilament light chain (NfL) levels may mark Spinal Muscular Atrophy (SMA) severity and therapy efficacy.
Although she finds travel difficult for herself, DeAnn Runge loves to hear about others adventures. Today she reads Halsey Blocher’s column, “Vacationing With SMA as Your Travel Companion,” where she shares about her family trip to Florida and tips to make the journey as easy as it can be.
Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/